title: Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease.
abstract: We report a case of probable Zaire Ebola virus-related ophthalmologic complications in a physician from the United States who contracted Ebola virus disease in Liberia. Uveitis, immune activation, and nonspecific increase in antibody titers developed during convalescence. This case highlights immune phenomena that could complicate management of Ebola virus disease-related uveitis during convalescence.
authors.forename: John R
authors.initials: JR
authors.lastname: Chancellor
authors.forename: Sriranjani P
authors.initials: SP
authors.lastname: Padmanabhan
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Greenough
authors.forename: Richard
authors.initials: R
authors.lastname: Sacra
authors.forename: Richard T
authors.initials: RT
authors.lastname: Ellison
authors.forename: Lawrence C
authors.initials: LC
authors.lastname: Madoff
authors.forename: Rebecca J
authors.initials: RJ
authors.lastname: Droms
authors.forename: David M
authors.initials: DM
authors.lastname: Hinkle
authors.forename: George K
authors.initials: GK
authors.lastname: Asdourian
authors.forename: Robert W
authors.initials: RW
authors.lastname: Finberg
authors.forename: Ute
authors.initials: U
authors.lastname: Stroher
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Uyeki
authors.forename: Olga M
authors.initials: OM
authors.lastname: Cerón
mesh_terms: D029043:Ebolavirus / Q000235:genetics; D019142:Hemorrhagic Fever, Ebola / Q000150:complications* / Q000175:diagnosis / Q000821:virology*; D006801:Humans; D007988:Liberia; D008297:Male; D041623:Tomography, Optical Coherence; D014605:Uveitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*
keywords: Ebola; Ebola hemorrhagic fever; Ebola virus; Ebola virus disease; Liberia; conjunctivitis; convalescent phase; immune privilege; ocular manifestations; systemic inflammatory markers; uveitis; viruses
references.citation: Am J Ophthalmol. 2005 Sep;140(3):509-16
references.pmid: 16196117
references.citation: Am J Ophthalmol. 2010 Nov;150(5):637-641.e1
references.pmid: 20719302
references.citation: N Engl J Med. 2014 Oct 16;371(16):1481-95
references.pmid: 25244186
references.citation: Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24
references.pmid: 25775592
references.citation: MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):479-81
references.pmid: 25950255
references.citation: Surv Ophthalmol. 2005 Jul-Aug;50(4):364-88
references.pmid: 15967191
references.citation: Clin Infect Dis. 2015 Aug 15;61(4):496-502
references.pmid: 25904375
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S1-7
references.pmid: 9988155
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S13-4
references.pmid: 9988158
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S170-6
references.pmid: 9988181
references.citation: N Engl J Med. 2015 Jun 18;372(25):2423-7
references.pmid: 25950269